Orchid Jahanshahi
Roles: Associate, Investigator
Sites: CDL-Rockies, CDL-Toronto, CDL-Vancouver
Streams: Biomedical Engineering, Cancer, Neuro
Orchid Jahanshahi is the founder of ThinkrBelle, a trailblazing advisory firm bridging commercial solutions between Biopharma and Tech. With nearly 30 years of commercial leadership across global pharma, startups, and investment, she brings unmatched cross-sector fluency to solving complex challenges.
She’s held senior roles in marketing, sales, and global brand strategy at six Fortune 500 pharmaceutical companies, launching treatments across neuroscience, MS, cardiovascular, oncology, hematology, and wound care. In 2020, Orchid pivoted into AI and tech, joining NuEnergy.AI to champion responsible governance of AI, and ODAIA, where she led an 8x revenue growth in two years, culminating in a successful exit in 2023.
Through ThinkrBelle, she advises pharma and biotech companies on scaling digital solutions and serves as a strategic “Sherpa” for Canadian HealthTech startups, helping them land real, paid engagements with pharma.
An active angel investor in four biotech and digital health ventures, Orchid also serves on the boards of Kinark Child & Family Services and Canadian Entrepreneurs in Life Sciences (CELS), where she helps Canadian founders secure investment and partnerships in Silicon Valley. She holds an MBA from Ivey Business School and is Entrepreneur-in-Residence at the Morrissette Institute for Entrepreneurship at University of Western Ontario.
Orchid brings a rare combination of Big Pharma depth, startup speed, and a human-first mindset—working to build a smarter, more connected future for healthcare.